A 54-year-old man with long-standing type 2 diabetes and obesity is found to have persistently elevated alanine aminotransferase and ultrasound evidence of hepatic steatosis. He does not drink alcohol. According to recent Canadian guidance on steatotic liver disease in diabetes, what is the cornerstone of his management?